Preview Mode Links will not work in preview mode

Jul 27, 2020

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers — Interview with Dr O’Malley on the following topics:

  • Emerging efficacy and safety data with and ongoing investigation of tisotumab vedotin in the management of gynecologic cancers (00:00)
  • Dual ICI combination regimens under investigation for gynecologic cancers (3:50)
  • Clinical care of patients with HER2-positive endometrial cancer (8:39)
  • Efficacy and tolerability of pembrolizumab/lenvatinib in patients with microsatellite-stable endometrial cancer (12:01)

CME information and select publications